Allosteric modulation of conserved motifs and helices in 5HT_2BR: Advances drug discovery and therapeutic approach towards drug resistant epilepsy

References

• Aghajanian, G. K., & Marek, G. J. (1997). Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology, 36(4–5), 589–599. https://doi.org/10.1016/s0028-3908(97)00051-8
   PubMed Web of Science ®Google Scholar
• Akyuz, E., Doganyigit, Z., Paudel, Y. N., Koklu, B., Kaymak, E., Villa, C., Arulsamy, A., Shaikh, M. F., & Devinsky, O. (2021). Immunoreactivity of Muscarinic Acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy. Life, 11(4), 276. https://doi.org/10.3390/life11040276
   PubMedGoogle Scholar
• Arimont, M., Van Der Woude, M., Leurs, R., Vischer, H. F., De Graaf, C., & Nijmeijer, S. (2019). Identification of key structural motifs involved in 7 transmembrane signaling of adhesion GPCRs. ACS Pharmacology & Translational Science, 2(2), 101–113. https://doi.org/10.1021/acsptsci.8b00051
   Google Scholar
• Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263. https://doi.org/10.1093/nar/gky318
   PubMed Web of Science ®Google Scholar
• Benfenati, E., Manganaro, A., Gini, G. (2013). VEGA-QSAR: AI inside a platform for predictive toxicology. In CEUR Workshop Proceedings (Vol. 1107, pp. 21–28). CEUR-WS.
   Google Scholar
• Bonhaus, D. W., Bach, C., DeSouza, A., Salazar, F. H., Matsuoka, B. D., Zuppan, P., Chan, H. W., & Eglen, R. M. (1995). The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. British Journal of Pharmacology, 115(4), 622–628. https://doi.org/10.1111/j.1476-5381.1995.tb14977.x
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., et al. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In SC'06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, 43. IEEE.
   Google Scholar
• Brodie, M. J. (2010). Antiepileptic drug therapy the story so far. Seizure, 19(10), 650–655. https://doi.org/10.1016/j.seizure.2010.10.027
   PubMed Web of Science ®Google Scholar
• Ciranna, Á. (2006). Serotonin as a modulator of glutamate-and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Current Neuropharmacology, 4(2), 101–114. https://doi.org/10.2174/157015906776359540
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Epilepsy: new advances - PubMed. (2022). [Internet]. [cited 2022 Jan 10]. Available from: https://pubmed.ncbi.nlm.nih.gov/25260236/.
   Google Scholar
• Fawley, J. A., Doyle, M. W., & Andresen, M. C. (2019). 5-HT3R–sourced calcium enhances glutamate release from a distinct vesicle pool. Brain Research, 1721, 146346. https://doi.org/10.1016/j.brainres.2019.146346
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gong, Y., Fu, W., & Chen, K. (2012). Dopamine D1 receptor and serotonin 5-HT1A receptor agonist effects of the natural product (–)-stepholidine: molecular modelling and dynamics simulations. Molecular Simulation, 38(12), 970–979. https://doi.org/10.1080/08927022.2012.679619
   Web of Science ®Google Scholar
• Griffin, A. L., Jaishankar, P., Grandjean, J.-M., Olson, S. H., Renslo, A. R., & Baraban, S. C. (2019). Zebrafish studies identify serotonin receptors mediating anti-epileptic activity in Dravet syndrome. Brain Communications, 1(1), fcz008. https://doi.org/10.1093/braincomms/fcz008
   PubMedGoogle Scholar
• Hajian-Tilaki, K. (2013). Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian Journal of Internal Medicine, 4(2), 627.
   PubMedGoogle Scholar
• Hasuo, H., Matsuoka, T., & Akasu, T. (2002). Activation of presynaptic 5-hydroxytryptamine 2A receptors facilitates excitatory synaptic transmission via protein kinase C in the dorsolateral septal nucleus. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 22(17), 7509–7517. https://doi.org/10.1523/JNEUROSCI.22-17-07509.2002
   PubMed Web of Science ®Google Scholar
• Isaac, M. (2005). Serotonergic 5-HT2C receptors as a potential therapeutic target for the design anti-epileptic drugs. Current Topics in Medicinal Chemistry, 5(1), 59–67. https://doi.org/10.2174/1568026053386980
   PubMed Web of Science ®Google Scholar
• Ishchenko, A., Wacker, D., Kapoor, M., Zhang, A., Han, G. W., Basu, S., Patel, N., Messerschmidt, M., Weierstall, U., Liu, W., Katritch, V., Roth, B. L., Stevens, R. C., & Cherezov, V. (2017). Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody. Proceedings of the National Academy of Sciences of the United States of America, 114(31), 8223–8228. https://doi.org/10.1073/pnas.1700891114
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Löscher, W. (2005). How to explain multidrug resistance in epilepsy? Epilepsy Currents, 5(3), 107–112. https://doi.org/10.1111/j.1535-7511.2005.05311.x
   PubMedGoogle Scholar
• Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020). Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacological Reviews, 72(3), 606–638. https://doi.org/10.1124/pr.120.019539
   PubMed Web of Science ®Google Scholar
• Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83–85. https://doi.org/10.1038/356083a0
   PubMed Web of Science ®Google Scholar
• Madeira, F., Pearce, M., Tivey, A. R., Basutkar, P., Lee, J., Edbali, O., Madhusoodanan, N., Kolesnikov, A., & Lopez, R. (2022). Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Research, 50(W1), W276–9. https://doi.org/10.1093/nar/gkac240
   PubMed Web of Science ®Google Scholar
• Mahler, B., Carlsson, S., Andersson, T., & Tomson, T. (2018). Risk for injuries and accidents in epilepsy: a prospective population-based cohort study. Neurology, 90(9), e779-89–e789. https://doi.org/10.1212/WNL.0000000000005035
   Web of Science ®Google Scholar
• Manford, M. (2017). Recent advances in epilepsy. Journal of Neurology, 264(8), 1811–1824. https://doi.org/10.1007/s00415-017-8394-2
   PubMed Web of Science ®Google Scholar
• Martínez-Archundia, M., & Correa-Basurto, J. (2014). Molecular dynamics simulations reveal initial structural and dynamic features for the A2AR as a result of ligand binding. Molecular Simulation, 40(13), 996–1014. https://doi.org/10.1080/08927022.2013.835485
   Web of Science ®Google Scholar
• Maura, G., Carbone, R., Guido, M., Pestarino, M., & Raiteri, M. (1991). 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. European Journal of Pharmacology, 202(2), 185–190. https://doi.org/10.1016/0014-2999(91)90293-Y
   PubMed Web of Science ®Google Scholar
• McCorvy, J. D., & Roth, B. L. (2015). Structure and function of serotonin G protein coupled receptors. Pharmacology & Therapeutics, 150, 129–142. https://doi.org/10.1016/j.pharmthera.2015.01.009
   PubMed Web of Science ®Google Scholar
• Millan, M. J., Loiseau, F., Dekeyne, A., Gobert, A., Flik, G., Cremers, T. I., Rivet, J.-M., Sicard, D., Billiras, R., & Brocco, M. (2008). S33138 (N-[4-[2-[(3aS, 9bR)-8-cyano-1, 3a, 4, 9b-tetrahydro [1] benzopyrano [3, 4-c] pyrrol-2 (3H)-yl)-ethyl] phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects. The Journal of Pharmacology and Experimental Therapeutics, 324(3), 1212–1226. https://doi.org/10.1124/jpet.107.134536
   PubMed Web of Science ®Google Scholar
• Murugesan, A., Rani, M. R. S., Vilella, L., Lacuey, N., Hampson, J. P., Faingold, C. L., Friedman, D., Devinsky, O., Sainju, R. K., Schuele, S., Diehl, B., Nei, M., Harper, R. M., Bateman, L. M., Richerson, G., & Lhatoo, S. D. (2019). Postictal serotonin levels are associated with peri-ictal apnea. Neurology, 93(15), e1485–e1494. https://doi.org/10.1212/WNL.0000000000008244
   PubMed Web of Science ®Google Scholar
• Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Shoichet, Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. https://doi.org/10.1021/jm300687e
   PubMed Web of Science ®Google Scholar
• Picot, M. C., Baldy‐Moulinier, M., Daurès, J. P., Dujols, P., & Crespel, A. (2008). The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population‐based study in a Western European country. Epilepsia, 49(7), 1230–1238. https://doi.org/10.1111/j.1528-1167.2008.01579.x
   PubMed Web of Science ®Google Scholar
• Pithadia, A. B., & Jain, S. M. (2009). 5-Hydroxytryptamine receptor subtypes and their modulators with therapeutic potentials. Journal of Clinical Medicine Research, 1(2), 72–80. https://doi.org/10.4021/jocmr2009.05.1237
   PubMedGoogle Scholar
• Pontius, J., Richelle, J., & Wodak, S. J. (1996). Deviations from standard atomic volumes as a quality measure for protein crystal structures. Journal of Molecular Biology, 264(1), 121–136. https://doi.org/10.1006/jmbi.1996.0628
   PubMed Web of Science ®Google Scholar
• Przegaliński, E., Baran, L., & Siwanowicz, J. (1994). Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl) phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice. Epilepsia, 35(4), 889–894. https://doi.org/10.1111/j.1528-1157.1994.tb02528.x
   PubMed Web of Science ®Google Scholar
• Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., Mathiesen, J. M., Shah, S. T. A., Lyons, J. A., Caffrey, M., Gellman, S. H., Steyaert, J., Skiniotis, G., Weis, W. I., Sunahara, R. K., & Kobilka, B. K. (2011). Crystal structure of the β 2 adrenergic receptor–Gs protein complex. Nature, 477(7366), 549–555. https://doi.org/10.1038/nature10361
   PubMed Web of Science ®Google Scholar
• Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009). The structure and function of G-protein-coupled receptors. Nature, 459(7245), 356–363. https://doi.org/10.1038/nature08144
   PubMed Web of Science ®Google Scholar
• Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., et al. (2000). Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation, 102(23), 2836–2841. https://doi.org/10.1161/01.CIR.102.23.2836
   PubMed Web of Science ®Google Scholar
• Sangwan, N., Singh, J., Chauhan, A., Prakash, A., Khanduja, K. L., Medhi, B., & Avti, P. K. (2022a). Terpenoid analogues as putative therapeutic agents towards glutathione peroxidase (GPX4) in neurodegenerative disorders: a dynamic computational approach. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2022.2086923
   Web of Science ®Google Scholar
• Sangwan, N., Singh, J., Chauhan, A., Prakash, A., Khanduja, K. L., Medhi, B., & Avti, P. K. (2022b). Structure and dynamic simulation-based interactions of benzenoids, pyrroles and organooxygen compounds for effective targeting of GPX4 in ischemic stroke. Journal of Biomolecular Structure and Dynamics, 30, 1–14. https://doi.org/10.1080/07391102.2022.2141889
   Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Scharfman, H. E. (2007). The neurobiology of epilepsy. Current Neurology and Neuroscience Reports, 7(4), 348–354. https://doi.org/10.1007/s11910-007-0053-z
   PubMed Web of Science ®Google Scholar
• Schrödinger Release. (2021). Schrödinger Release 2022-3: LigPrep. Schrödinger, LLC.
   Google Scholar
• Shellhaas, R. A. (2019). Seizure classification, etiology, and management. Handbook of Clinical Neurology, 162, 347–361. https://doi.org/10.1016/B978-0-444-64029-1.00017-5
   PubMedGoogle Scholar
• Silberstein, S. D. (1998). Methysergide (421–435). Wiley. https://doi.org/10.1046/j.1468-2982.1998.1807421.x
   Google Scholar
• Tfelt-Hansen, P., Saxena, P. R., Dahlöf, C., Pascual, J., Láinez, M., & Henry, P. (2000). Ergotamine in the acute treatment of migraine: A review and European consensus. Brain, 123(1), 9–18. https://doi.org/10.1093/brain/123.1.9
   PubMed Web of Science ®Google Scholar
• Tolete, P., Knupp, K., Karlovich, M., DeCarlo, E., Bluvstein, J., Conway, E., Friedman, D., Dugan, P., & Devinsky, O. (2018). Lorcaserin therapy for severe epilepsy of childhood onset: A case series. Neurology, 91(18), 837–839. https://doi.org/10.1212/WNL.0000000000006432
   PubMed Web of Science ®Google Scholar
• Upton, N., Stean, T., Middlemiss, D., Blackburn, T., & Kennett, G. (1998). Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. European Journal of Pharmacology, 359(1), 33–40. https://doi.org/10.1016/s0014-2999(98)00621-9
   PubMed Web of Science ®Google Scholar
• Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., Shoichet, B. K., Dror, R. O., & Roth, B. L. (2017). Crystal structure of an LSD-bound human serotonin receptor. Cell, 168(3), 377–389.e12. https://doi.org/10.1016/j.cell.2016.12.033
   PubMed Web of Science ®Google Scholar
• Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X. P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., Liu, W. (2013). Structural features for functional selectivity at serotonin receptors. Science, 340(6132), 615–9.
   PubMed Web of Science ®Google Scholar
• Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., McCorvy, J. D., Gao, X., Zhou, X. E., Melcher, K., Zhang, C., Bai, F., Yang, H., Yang, L., Jiang, H., … Xu, H. E. (2013). Structural basis for molecular recognition at serotonin receptors. Science (New York, NY), 340(6132), 610–614. https://doi.org/10.1126/science.1232807
   Google Scholar
• Wang, Y., Wang, Q., Huang, H., Huang, W., Chen, Y., McGarvey, P. B., Wu, C. H., & Arighi, C. N., UniProt Consortium. (2021). A crowdsourcing open platform for literature curation in UniProt. PLoS Biology, 19(12), e3001464. https://doi.org/10.1371/journal.pbio.3001464
   PubMed Web of Science ®Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Wu, G., Wang, L., Hong, Z., Ren, S., & Zhou, F. (2017). Hippocampal low-frequency stimulation inhibits afterdischarge and increases GABA (A) receptor expression in amygdala-kindled pharmacoresistant epileptic rats. Neurological Research, 39(8), 733–743. https://doi.org/10.1080/01616412.2017.1325120
   PubMed Web of Science ®Google Scholar
• Xie, G., Zuo, W., Wu, L., Li, W., Wu, W., Bekker, A., & Ye, J. H. (2016). Serotonin modulates glutamatergic transmission to neurons in the lateral habenula. Scientific Reports, 6(1), 1–1. https://doi.org/10.1038/srep23798
   PubMedGoogle Scholar
• Yuan, S., Filipek, S., Palczewski, K., & Vogel, H. (2014). Activation of G-protein-coupled receptors correlates with the formation of a continuous internal water pathway. Nature Communications, 5(1), 1–0. https://doi.org/10.1038/ncomms5733
   Google Scholar